120 related articles for article (PubMed ID: 3943108)
1. Cytosuppressive effect of bromocriptine on human prolactinomas: stereological analysis of ultrastructural alterations with special reference to secretory granules.
Saitoh Y; Mori S; Arita N; Hayakawa T; Mogami H; Matsumoto K; Mori H
Cancer Res; 1986 Mar; 46(3):1507-12. PubMed ID: 3943108
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of bromocriptine on estrogen-induced rat prolactinomas: ultrastructural alterations of secretory granules.
Saitoh Y; Koizumi K; Arita N; Hayakawa T; Mogami H; Matsumoto K; Mori H
Anticancer Res; 1986; 6(5):1149-55. PubMed ID: 3800323
[TBL] [Abstract][Full Text] [Related]
3. Decreased prolactin level in secretory granules and their increased exocytosis in estrogen-induced pituitary hyperplasia in rats treated with a dopamine agonist.
Maeda T; Sawada K; Itoh Y; Moriwaki K; Mori H
Lab Invest; 1991 Dec; 65(6):679-87. PubMed ID: 1753713
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor effect of bromocriptine on estrogen-induced rat prolactinomas: special reference to changes in secretory granules by stereological analysis].
Saitoh Y; Koizumi K; Arita N; Hayakawa T; Aono T; Matsumoto K; Mogami H; Mori H
No To Shinkei; 1987 Apr; 39(4):347-54. PubMed ID: 3593602
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural morphometry of prolactin secreting adenomas treated with dopamine agonists.
Schottke H; Saeger W; Lüdecke DK; Caselitz J
Pathol Res Pract; 1986 Jun; 181(3):280-90. PubMed ID: 3748874
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous sparsely-granulated prolactin-producing pituitary adenomas in aging rats. A prospective study of the effect of bromocriptine.
McComb DJ; Hellmann P; Kovacs K; Scott D; Evans WS; Burdman JA; Thorner MO
Neuroendocrinology; 1985 Sep; 41(3):201-11. PubMed ID: 4047338
[TBL] [Abstract][Full Text] [Related]
7. Pathology of prolactin cell adenomas of the human pituitary.
Horvath E; Kovacs K
Semin Diagn Pathol; 1986 Feb; 3(1):4-17. PubMed ID: 3303229
[TBL] [Abstract][Full Text] [Related]
8. Bromocriptine treatment of pituitary adenomas. Evaluation of withdrawal effect.
Coculescu M; Simionescu N; Oprescu M; Alessandrescu D
Endocrinologie; 1983; 21(3):157-68. PubMed ID: 6635518
[TBL] [Abstract][Full Text] [Related]
9. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
Teramoto A; Sanno N; Tahara S; Osamura YR
Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
[TBL] [Abstract][Full Text] [Related]
10. In-vitro effects of bromocriptine on isolated pituitary adenoma cells. Ultrastructural and morphometrical studies.
Saeger W; Thiel M; Caselitz J; Lüdecke DK
Pathol Res Pract; 1985 Dec; 180(6):697-704. PubMed ID: 3832005
[TBL] [Abstract][Full Text] [Related]
11. Changes in prolactinomas and somatotropinomas in humans treated with bromocriptine.
Mori H; Maeda T; Saitoh Y; Onishi T
Pathol Res Pract; 1988 Sep; 183(5):580-3. PubMed ID: 3237547
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine treatment reduces the cell size in human macroprolactinomas: a morphometric study.
Bassetti M; Spada A; Pezzo G; Giannattasio G
J Clin Endocrinol Metab; 1984 Feb; 58(2):268-73. PubMed ID: 6693536
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of secretory granules of silent pituitary adenomas.
Holck S; Wewer UM; Albrechtsen R
Mod Pathol; 1988 May; 1(3):212-5. PubMed ID: 3237702
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural localization of prolactin in the human pituitary prolactinomas and its changes by bromocriptine treatment.
Osamura RY; Teramoto A; Watanabe K
Acta Pathol Jpn; 1986 Aug; 36(8):1123-30. PubMed ID: 3776529
[TBL] [Abstract][Full Text] [Related]
15. [Effect of tamoxifen on the treatment of pituitary adenomas with bromocriptine].
Yamashita M; Hirakawa T; Tashiro Y; Matsuda T; Kibe M; Fukushima T; Tomonaga M
No Shinkei Geka; 1987 Jan; 15(1):65-72. PubMed ID: 3822068
[TBL] [Abstract][Full Text] [Related]
16. Increased exocytosis of secretory granules in contrast to reduced serum hormone levels in pituitary adenomas of humans and rats treated with dopamine agonist.
Mori H; Saitoh Y; Maeda T; Okada Y; Hirano H; Tsuji M
Med Electron Microsc; 2001 Jun; 34(2):123-33. PubMed ID: 11685661
[TBL] [Abstract][Full Text] [Related]
17. In vitro short-term effects of SMS 201-995, bromocriptine and TRH on growth hormone cell morphology from human pituitary adenomas.
García García J; Jiménez Reina L; García Luna PP; Leal Cerro A; Astorga Jiménez R; García García-Revillo J; Bernal Valls G
Histol Histopathol; 1989 Apr; 4(2):223-33. PubMed ID: 2520459
[TBL] [Abstract][Full Text] [Related]
18. [Pathological changes of prolactinomas treated with bromocriptine].
Teramoto A; Takakura K; Fukushima T; Osamura Y
No Shinkei Geka; 1982 Jun; 10(6):619-27. PubMed ID: 7121729
[TBL] [Abstract][Full Text] [Related]
19. Bromocriptine effects on cultured human prolactin-producing pituitary adenomas: in vitro ultrastructural, morphometric, and immunoelectron microscopic studies.
Hassoun J; Jaquet P; Devictor B; Andonian C; Grisoli F; Gunz G; Toga M
J Clin Endocrinol Metab; 1985 Oct; 61(4):686-92. PubMed ID: 4031013
[TBL] [Abstract][Full Text] [Related]
20. Morphologic effects of bromocriptine on spontaneously occurring pituitary prolactin-cell hyperplasia in old Long-Evans rats.
McComb DJ; Hellmann P; Thorner MO; Scott D; Evans WS; Kovacs K
Am J Pathol; 1986 Jan; 122(1):7-16. PubMed ID: 3942200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]